Skip to main content

Table 1 Inclusion criteria of the study protocol

From: The effectiveness of antioxidant vitamins C and E in reducing myocardial infarct size in patients subjected to percutaneous coronary angioplasty (PREVEC Trial): study protocol for a pilot randomized double-blind controlled trial

Inclusion criteria

1

Subjects may be of either sex and must be at least 18 years old

2

Subjects must have indication of primary percutaneous coronary angioplasty (PCA):

 

-Angina or equivalent at least 120 minutes in duration

 

- Electrocardiogram with ST-segment elevation myocardial infarction that concerns

more than two contiguous leads (>2 mm)

3

Presentation within 12 hours of symptoms onset

4

First myocardial infarction

5

Primary PCA must show a pre-PCA TIMI flow of 0

6

Subject must be able and willing to sign informed consent